Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Inhalation Sciences receives new order worth 1.4 MSEK from VITO, the Flemish Institute for Technological Research

(Stockholm, 30 October 2020) One of Europe’s most innovative research organisations, driving new technology worldwide in sustainable health, chemistry, energy and land use, is purchasing PreciseInhale[®], ISAB’s high-precision aerosol R&D system, together with its Particle Size Determination kit and Inhaler Aerosol Generator option for both DPI and /pMDI inhalers. The combined value of the order is 1.4 MSEK.ISAB’s new customer develops new technology solutions in sustainability across a wide range of research areas. A major one is health – where the company partner with governments and

Kielo acquires in Helsinki Metropolitan Area (HMA)

The real estate company Kielo, managed by Brunswick Real Estate, has acquired an office property (Martintalo) in the Finnish city of Vantaa 20 kilometers outside Helsinki. The property built in 1992 comprises 14,000 square meters of office space and is located with good transportation and connections in Vantaa and greater Helsinki area.   Hanna Rauhala, Fund Manager at Brunswick Real Estate, says: “The Martintalo property with its great location and diversified tenant mix makes a perfect fit in the Kielo strategy and we believe we can further enhance the property with our

Correction: Fiskars Group interim report January-September 2020

Fiskars CorporationStock Exchange ReleaseOctober 30, 2020 at 9:30 a.m. (EET) Correction: Fiskars Group interim report January-September 2020This is a correction to Fiskars Corporation's Stock Exchange Release issued on October 30, 2020 at 8:30 EET regarding Fiskars' interim report January-September 2020. In the English version of the release, the figures for January-September 2020 in brief were incorrect. The figures in the attachment were correct.   Strong progress during the third quarter driven by exceptionally good demand in several categories as well as savings actions

Change in number of shares and votes in Endomines

Endomines AB, Stock Exchange Release 30 October 2020 at 08:30 CET The total number of shares and votes in Endomines AB (publ) ("Endomines") amounts to 131,305,175 as at 30 October 2020. The number of shares and votes in Endomines has increased by 15,392,535 during the month of October following the directed share issue to Transatlantic Mining informed on 8 of October, 2020. Following the above-mentioned measures, the shares in Endomines amount to 131,305,175 and the share capital amounts to SEK 394,385,153.61.Contact personMarcus Ahlström, Deputy CEO and CFO, +358 50 544 6814,

YIT Corporation’s financial reporting and Annual General Meeting in 2021

YIT Corporation   Stock Exchange Release   30 October 2020 at 9.30 a.m.YIT Corporation’s financial reporting and Annual General Meeting in 2021 YIT will publish the Financial Statements bulletin for 2020 on Wednesday, 3 February 2021. Financial Statements 2020 will be published during week 8/2021 at the latest. In addition, YIT will publish two interim reports and a half-year report in 2021: · Interim report for January-March on Friday, 30 April 2021 · Half-year report for January-June on Friday, 30 July 2021 · Interim report for January-September on Friday, 29 October 2021

SciBase releases next generation platform, Nevisense Go.

STOCKHOLM, SWEDEN, — October 30, 2020 – SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the release of the first device based on their new platform, Nevisense Go.Nevisense Go is a handheld and fully portable device the size of a large Pen. It combines the company’s core Electrical Impedance Spectroscopy (EIS) measurement technology with a new AI-based analysis platform embedded in the device. The result is a flexible platform that will be significantly easier to both collect data and develop

Buy-backs of shares of series B in Saab during week 43-44 2020

During the period 23 October – 29 October 2020, Saab AB (publ) (LEI code 549300ZHO4JCQQI13M69) has repurchased in total 630.000 own shares of series B (ISIN: SE0000112385) as part of the share buy-back programme initiated by the Board of Directors in order to secure delivery of shares to participants in Saab’s long-term Share Matching Plan, Performance Share Plan and Special Projects Incentive.The share buy-back programme, which Saab announced on 16 September 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the Commission Delegated

NextCell publishes its Year-End Report

NextCell Pharma AB (publ) (NXTCL) publishes its Year-End Report for the period September 1, 2019 - August 31, 2020 The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-reportNextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.   Twelve months (2019-09-01 until 2020-08-31)● Operating income amounted to SEK 4 166 123 (1 964 132).● Operating result amounted to SEK -17 680 697 (-17 997 787).● Earnings per share* amounted

Atacand to be divested to Cheplapharm in more than 70 countries

30 October 2020 07:00 GMT Atacand to be divested to Cheplapharm in more than 70 countries Agreement supports strategy of focusing on newer medicines in main therapy areas AstraZeneca has agreed to sell the commercial rights to Atacand(candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in around 70 countries globally to Cheplapharm Arzneimittel GmbH (Cheplapharm). Atacand is a prescription medicine approved for the treatment of heart failure (HF) and hypertension. Atacand Plus is approved for the treatment of

Axolot Solutions Holding AB (publ) - Interim report January-September 2020

The launch of a new model program and the first commercial sales of an AxoPur system represent a take-off into the future for AxolotSummary of the third quarter 2020 Financially · Net sales amounted to 621 tsek (485 tsek for the corresponding quarter in 2019), referring to trial runs mainly in Sweden and Finland. · Other revenues were -3 tsek (3). · Earnings before interest and tax became -4 356 tsek (-5 506), where the improved results relate to an increase in trial runs and to effects from Axolot’s Covid-19 related restructuring measures on the cost side. · Net earnings

Notice of extra general meeting in Embracer Group AB

The shareholders of Embracer Group AB, reg. no. 556582-6558, (the "Company") are hereby invited to the extra general meeting on Monday 16 November 2020 at 10.00 CET at Baker McKenzie's premises at Vasagatan 7 in Stockholm.Information with respect to the coronavirus Due to the development of the coronavirus the goal is that the general meeting shall be swift and effective to minimize spread of disease. Shareholders should carefully consider the possibility to vote in advance, please see below, as well as the possibility of participating by way of proxy. Shareholders who display symptoms

Exel Composites' Business Review Q1-Q3 2020: Revenue and operating profit increased

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE      30 OCTOBER 2020 at 09:00 EETQ3 2020 in brief  · Order intake decreased by 9.5% to EUR 24.5 million (Q3 2019: 27.1).  · Revenue increased by 10.2% to EUR 26.0 million (23.6).  · Adjusted operating profit increased to EUR 2.0 million (1.7), which is 7.8% of revenue (7.0).  · Operating profit increased to EUR 2.0 million (1.5), which is 7.8% of revenue (6.2). · Earnings per share amounted to EUR 0.09 (0.07). Q1-Q3 2020 in brief  · Order intake increased by 3.6% to EUR 81.9 million (Q1-Q3 2019: 79.0).  · Revenue

Interim report January-September 2020

July-September 2020 · Net sales were 355.4 MSEK (321.9), an increase of 10.4% from the equivalent quarter in 2019. Organic growth was 12.2% for the period. · Operating income was 45.7 MSEK (31.4), an operating margin of 12.9% (9.8%). · Earnings per share were 2.45 SEK (1.77). · Cash flow after investments was 74.6 MSEK (54.0). January-September 2020 · Net sales were 1,140.2 MSEK (969.4), an increase of 17.6% from the equivalent period in 2019. Organic growth was 7.4% for the period. · Operating income increased to 137.0 MSEK (71.6), an operating margin of 12.0% (10.

Nomination Committee appointed ahead of Collector’s AGM 2021

Collector AB (publ)’s Annual General Meeting will be held in Gothenburg, Sweden on Wednesday 5 May 2021. In accordance with a resolution at Collector’s Annual General Meeting held 27 April 2020, it is hereby announced that the company’s largest shareholders have appointed a Nomination Committee.The Nomination Committee has, ahead of the Annual General Meeting 2021, the following composition: · Sharam Rahi, appointed by Fastighets AB Balder · Anna-Maria Lundström, appointed by StrategiQ Capital AB · Lena Apler, appointed by Helichrysum Gruppen AB · Erik Selin, Chairman of the

Conversion of shares

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.In October, at the request of shareholders, 70 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 1,257,959,127.The total number of registered shares in the company amounts to 702,342,489 of which  61,735,182 are Class A

Annual General Meeting 2021 and information about appointed members to the Nomination Committee

The 2021 Annual General Meeting (AGM) of Nexam Chemical Holding AB (publ) will be held on Tuesday, 11[th ]of May 2021, at 3:00 pm, at Elite Hotel Ideon, Scheelevägen 27 in Lund, Sweden.Shareholders are entitled to have items put on the agenda for the Annual General Meeting, if a request has been received by the Board of Directors no later than 11[th] of March 2021. The Board of Directors can be contacted via email at: styrelsen@nexamchemical.com or by regular mail addressed to: Nexam Chemical Holding AB (publ), Att: Board of Directors Box 165, 234 23 LOMMA, Sweden.At the Annual General

Taavi Heikkilä to join Metsäliitto Cooperative’s Board of Directors

Metsä Group Stock Exchange Release, 30 October 2020 at 9.00 EETAt a meeting held on 29 October 2020, the Supervisory Board of Metsä Group’s parent company, Metsäliitto Cooperative, elected Taavi Heikkilä, vuorineuvos (Finnish honorary title), to be a new member of Metsäliitto Cooperative’s Board of Directors during the three year period of 2021-2023. Heikkilä has an extensive work experience from different managerial positions in S Group. Since 2014 he has held the position of SOK’s Chairman and CEO, which he has announced to leave after his successor is appointed and is able to commence

Electrolux Professional AB interim report Q3 2020

Third quarter, July – September 2020· The COVID-19 pandemic continued to impact the business. Net sales amounted to SEK 1,748m (2,190). Sales decreased by 20.2%. Organically sales decreased by 16.1%. · EBITA amounted to SEK 96m (144), corresponding to a margin of 5.5% (6.6). EBITA excluding items affecting comparability of SEK –77m (–122), amounted to SEK 173m (266), corresponding to a margin of 9.9% (12.1).  · Operating income amounted to SEK 81m (126), corresponding to a margin of 4.6% (5.7). · Operating cash flow after investments amounted to SEK 63m (134). · Income for the

NOTICE TO THE EXTRAORDINARY GENERAL MEETING IN HEXAGON AB (publ)

The shareholders of Hexagon AB are hereby given notice of the Extraordinary General Meeting to be held on Tuesday 1 December 2020. In light of the risk of the spread of the coronavirus and the authorities’ regulations/advice about avoiding gatherings, the Board of Directors has decided that the Extraordinary General Meeting shall be conducted without physical presence of shareholders, representatives or third parties and that the shareholders before the Meeting should be able to exercise their voting rights only by post. Information on the resolutions passed at the Meeting will be

Viking Line Abp: Managers' Transactions

Viking Line Abp       MANAGERS' TRANSACTIONS    30.10.2020, 9.00 AMManagers' transactionsViking Line Abp has on 29 October 2020 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from [aperson discharging managerial responsibilities in Viking Line Abp.Viking Line Abp - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Johansson JakobPosition: Member of the Board/Deputy memberIssuer: Viking Line AbpLEI: 743700CUWGW42AGIDN49 Notification type: INITIAL

Interim Report Q3 2020

· The publication paper market has been structurally declining for a long time and SCA decided in September to discontinue publication paper operations at the Ortviken industrial site. The production will be phased out during the first quarter of 2021. The discontinuation resulted in one-off items with a negative effect on EBITDA of SEK -1,120m. · The company is investing in an increased production of chemical thermomechanical pulp (CTMP). Production will increase from the current 100,000 tonnes to 300,000 tonnes per year and will be moved from Östrand to Ortviken JANUARY 1 –

There are no items matching the current filter
There are no more items matching the current filter
Back to top